N. BIBI and M. MALIK, “ COMPARISON OF 550MG/DAY VERSES 1100 MG/DAY RIFAXIMIN IN SECONDARY PREVENTION OF BOTH COVERT AND OVERT HEPATIC ENCEPHALOPATHY”, Pak J Intens Care Med, vol. 5, no. 01, p. 71, May 2025.